The owner of one of the three largest pharmacy middlemen in the United States last week filed suit to quash an attempt by the Federal Trade Commission to investigate industry practices. However, the suit relies on research that the health conglomerate helped pay for and was conducted by an economist who’s become wealthy arguing in […]
